Nektar Therapeutics (NASDAQ:NKTR)

5.14
Delayed Data
As of Aug 12
 +0.19 / +3.84%
Today’s Change
3.02
Today|||52-Week Range
19.37
-61.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues230.8M165.4M307.7M1.2B
 
 
 
 
 
Cost of Goods Sold29.2M25.0M24.9M21.2M
 
 
 
 
 
Depreciation And Amortization11.4M13.2M12.6M8.8M
 
 
 
 
 
 
Operating ExpensesGross Income190.2M127.3M270.2M1.2B
 
 
 
 
 
General Expenses216.5M240.1M309.2M475.4M
 
 
 
 
 
Research And Development176.3M195.9M260.1M394.0M
 
 
 
 
 
Total Operating Expenses257.2M278.3M346.7M505.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.4M-112.9M-39.0M687.9M
 
 
 
 
 
Extraordinary Charge-17.1M0.00-20.7M0.00
 
 
 
Interest Expense On Debt38.9M42.2M41.0M42.8M
 
 
 
 
 
Other Expenses1.7M2.4M4.5M37.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-80.7M-152.6M-96.1M682.7M
 
 
 
 
 
Income Taxes-506.0K-876.0K-616.0K-1.4M
 
 
 
 
 
Net Income-81.2M-153.5M-96.7M681.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.5M139.6M156.0M169.6M
 
 
 
 
 
Shares To Calculate EPS Diluted132.5M139.6M156.0M180.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.61-$1.10-$0.62$3.78
 
 
 
 
 
EPS Diluted-$0.61-$1.10-$0.62$3.78